Organogenesis director buys 10,000 ORGO shares

Organogenesis Holdings Inc. director Michael Joseph Driscoll bought 10,000 shares of Class A Common Stock in an open-market purchase.

Rhea-AI Filing Summary

Organogenesis Holdings Inc. director Michael Joseph Driscoll bought 10,000 shares of Class A Common Stock in an open-market purchase. He paid about $2.67 per share, for a total of roughly $26,688. Following this transaction, he directly owns 225,707 shares, making this a relatively small addition to his stake.

Insider Trade Summary

Net Buyer: 10,000 shares

Net Buy 1 txn

Insider Driscoll Michael Joseph

Role Director

Bought 10,000 shs ($27K)

Type	Security	Shares	Price	Value
Purchase	Class A Common Stock	10,000	$2.6688	$27K

Holdings After Transaction: Class A Common Stock — 225,707 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ORGO director Michael Driscoll report?

Michael Joseph Driscoll reported an open-market purchase of 10,000 Class A Common shares of Organogenesis Holdings Inc. He bought the shares on March 9, 2026, increasing his direct ownership position in the company.

At what price did Michael Driscoll buy ORGO stock on March 9, 2026?

He bought the shares at an average price of about $2.6688 per share. This implies a total purchase value of roughly $26,688, based on the reported transaction price and share count.

How many Organogenesis (ORGO) shares does Michael Driscoll own after this trade?

After the transaction, Michael Driscoll directly holds 225,707 shares of Organogenesis Class A Common Stock. The 10,000 shares purchased represent a modest increase relative to his overall reported holdings.

Is Michael Driscoll’s March 2026 ORGO trade a purchase or sale?

The March 9, 2026 Form 4 shows a purchase of Organogenesis stock. The transaction is coded “P,” indicating an open-market or private purchase rather than a sale or other type of disposition.

Does the March 2026 ORGO Form 4 involve derivative securities or options?

The reported transaction involves only non-derivative Class A Common Stock. The derivative securities section in the filing shows no entries, indicating no option exercises or other derivative transactions in this specific Form 4.

What does Michael Driscoll’s ORGO Form 4 mean for insider activity levels?

This Form 4 reflects a single open-market purchase of 10,000 shares, categorized as a net-buy. The filing shows no sales, option exercises, gifts, or restructuring transactions for this date, indicating straightforward buying activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 05:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Driscoll Michael Joseph

(Last) (First) (Middle)

C/O ORGANOGENESIS HOLDINGS INC.

85 DAN ROAD

(Street)

CANTON MA 02021

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Organogenesis Holdings Inc. [ ORGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/09/2026		P		10,000	A	$2.6688	225,707	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ William R. Kolb, Attorney-in-Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.